School of Medicine

Index of publications

• Articles
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
• Conference proceedings
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2005
  • 2004
  • 2003
  • 2002
  • 1995
  • 1992
  • 1990

Publications

• Articles
  • 2013
    • Topical steroid has the potential of modulating skin dendritic cells to tolerogenic antigen presenting cells in human organ skin bath culture
      Tatovic D, Pearton M, Birchall J, Wong S, Dayan C, Diabetic Medicine, Volume 30 (March 2013) pp.53-53
    • Assessment of an enzyme linked immunosorbent assay for zinc transporter 8 autoantibodies
      Dunseath GJ, Dayan C, Ananieva-Jordanova R, Powell M, Coles R, Furmaniak J, Rees-Smith B, Luzio SD, Diabetic Medicine, Volume 30 (March 2013) pp.54-54
  • 2012
    • Amiodarone-induced thyrotoxicosis, an overview of UK management.
      Raghavan RP, Taylor PN, Bhake R, Vaidya B, Martino E, Bartalena L, Dayan CM, Bradley K, Clin Endocrinol (Oxf), Volume 77, 6 (December 2012) pp.936-937
    • Pancreatic volume is reduced in adult patients with recently diagnosed type 1 diabetes.
      Williams AJ, Thrower SL, Sequeiros IM, Ward A, Bickerton AS, Triay JM, Callaway MP, Dayan CM, J Clin Endocrinol Metab, Volume 97, 11 (November 2012) pp.E2109-E2113
    • Basiliximab does not increase efficacy of corticosteroids in patients with steroid-refractory ulcerative colitis.
      Sands BE, Sandborn WJ, Creed TJ, Dayan CM, Dhanda AD, Van Assche GA, Greguš M, Sood A, Choudhuri G, Stempien MJ, Levitt D, Probert CS, Gastroenterology, Volume 143, 2 (August 2012) pp.356-64.e1
    • Circulating preproinsulin signal peptide-specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes and kill β-cells.
      Kronenberg D, Knight RR, Estorninho M, Ellis RJ, Kester MG, de Ru A, Eichmann M, Huang GC, Powrie J, Dayan CM, Skowera A, van Veelen PA, Peakman M, Diabetes, Volume 61, 7 (July 2012) pp.1752-1759
    • Development and preliminary evaluation of a psychosocial intervention for modifying psychosocial risk factors associated with foot re-ulceration in diabetes.
      Vedhara K, Beattie A, Metcalfe C, Roche S, Weinman J, Cullum N, Price P, Dayan C, Cooper AR, Campbell R, Chalder T, Behav Res Ther, Volume 50, 5 (May 2012) pp.323-332
    • Investigation of thyroid dysfunction is more likely in patients with high psychological morbidity.
      Bould H, Panicker V, Kessler D, Durant C, Lewis G, Dayan C, Evans J, Fam Pract, Volume 29, 2 (April 2012) pp.163-167
    • Orbital decompression for Graves' orbitopathy in England.
      Perros P, Chandler T, Dayan CM, Dickinson AJ, Foley P, Hickey J, Macewen CJ, Lazarus JH, McLaren J, Rose GE, Uddin JM, Vaidya B, Eye (Lond), Volume 26, 3 (March 2012) pp.434-437
    • Sedentary time, breaks in sedentary time and metabolic variables in people with newly diagnosed type 2 diabetes.
      Cooper AR, Sebire S, Montgomery AA, Peters TJ, Sharp DJ, Jackson N, Fitzsimons K, Dayan CM, Andrews RC, Diabetologia, Volume 55, 3 (March 2012) pp.589-599
    • Adipose tissue depot-specific differences in the regulation of hyaluronan production of relevance to Graves' orbitopathy.
      Zhang L, Grennan-Jones F, Lane C, Rees DA, Dayan CM, Ludgate M, J Clin Endocrinol Metab, Volume 97, 2 (February 2012) pp.653-662
    • NFκB and glucocorticoid receptor activity in steroid resistance.
      Dawson C, Dhanda A, Conway-Campbell B, Dimambro A, Lightman S, Dayan C, J Recept Signal Transduct Res, Volume 32, 1 (February 2012) pp.29-35
  • 2011
    • Diet or diet plus physical activity in patients with early type 2 diabetes Reply
      Andrews RC, Cooper AR, Montgomery AA, Peters TJ, Sharp DJ, Dayan CM, Lancet, Volume 378, 9809 (December 2011) pp.2067-2068
    • Smoking and strabismus surgery in patients with thyroid eye disease.
      Rajendram R, Bunce C, Adams GG, Dayan CM, Rose GE, Ophthalmology, Volume 118, 12 (December 2011) pp.2493-2497
    • Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation Initiative.
      Mallone R, Scotto M, Janicki CN, James EA, Fitzgerald-Miller L, Wagner R, Gottlieb P, Thorpe J, Jospe N, Durinovic-Bellò I, Boitard C, Lou O, Dayan CM, Wong FS, T-Cell Workshop Committee, Immunology of Diabetes Society None, Diabetes Metab Res Rev, Volume 27, 8 (November 2011) pp.720-726
    • Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.
      Hermanides J, Nørgaard K, Bruttomesso D, Mathieu C, Frid A, Dayan CM, Diem P, Fermon C, Wentholt IM, Hoekstra JB, DeVries JH, Diabet Med, Volume 28, 10 (October 2011) pp.1158-1167
    • Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death.
      Arif S, Moore F, Marks K, Bouckenooghe T, Dayan CM, Planas R, Vives-Pi M, Powrie J, Tree T, Marchetti P, Huang GC, Gurzov EN, Pujol-Borrell R, Eizirik DL, Peakman M, Diabetes, Volume 60, 8 (August 2011) pp.2112-2119
    • Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial.
      Andrews RC, Cooper AR, Montgomery AA, Norcross AJ, Peters TJ, Sharp DJ, Jackson N, Fitzsimons K, Bright J, Coulman K, England CY, Gorton J, McLenaghan A, Paxton E, Polet A, Thompson C, Dayan CM, Lancet, Volume 378, 9786 (July 2011) pp.129-139
    • A meta-analysis of the associations between common variation in the PDE8B gene and thyroid hormone parameters, including assessment of longitudinal stability of associations over time and effect of thyroid hormone replacement.
      Taylor PN, Panicker V, Sayers A, Shields B, Iqbal A, Bremner AP, Beilby JP, Leedman PJ, Hattersley AT, Vaidya B, Frayling T, Evans J, Tobias JH, Timpson NJ, Walsh JP, Dayan CM, Eur J Endocrinol, Volume 164, 5 (May 2011) pp.773-780
    • The clinical presentation of autoimmune thyroid disease in men is associated with IL12B genotype.
      Walsh JP, Berry J, Liu S, Panicker V, Dayan CM, Brix TH, Hegedüs L, Hou P, Shi B, Morahan G, Clin Endocrinol (Oxf), Volume 74, 4 (April 2011) pp.508-512
    • In vitro steroid resistance correlates with outcome in severe alcoholic hepatitis.
      di Mambro AJ, Parker R, McCune A, Gordon F, Dayan CM, Collins P, Hepatology, Volume 53, 4 (April 2011) pp.1316-1322
    • Commentary: testosterone and the metabolic syndrome: cause or consequence?
      Rees DA, Dayan CM, Int J Epidemiol, Volume 40, 1 (February 2011) pp.207-209
  • 2010
    • Coping style and depression influence the healing of diabetic foot ulcers: observational and mechanistic evidence
      Vedhara K, Miles JNV, Wetherell MA, Dawe K, Searle A, Tallon D, Cullum N, Day A, Dayan C, Drake N, Price P, Tarlton J, Weinman J, Campbell R, Diabetologia, Volume 53, 8 (August 2010) pp.1590-1598
    • IFN-gamma and IL-10 islet-antigen-specific T cell responses in autoantibody-negative first-degree relatives of patients with type 1 diabetes.
      Petrich de Marquesini LG, Fu J, Connor KJ, Bishop AJ, McLintock NE, Pope C, Wong FS, Dayan CM, Diabetologia, Volume 53, 7 (July 2010) pp.1451-1460
    • Distinct kinin-induced functions are altered in circulating cells of young type 1 diabetic patients.
      Kränkel N, Armstrong SP, McArdle CA, Dayan C, Madeddu P, Plos One, Volume 5, 6 (2010) p. e11146
    • THE RELATIONSHIP BETWEEN ANXIETY, DEPRESSION AND THYROID FUNCTION IN SUBJECTS ON AND NOT ON THYROXINE: THE HUNT POPULATION STUDY
      Panicker V, Evans J, Bjoro T, Asvold BO, Dayan CM, Bjerkeset O, European Psychiatry, Volume 25 (2010)
  • 2009
    • A paradoxical difference in relationship between anxiety, depression and thyroid function in subjects on and not on T4: findings from the HUNT study.
      Panicker V, Evans J, Bjøro T, Asvold BO, Dayan CM, Bjerkeset O, Clin Endocrinol (Oxf), Volume 71, 4 (October 2009) pp.574-580
    • Steroid refractory CD4+ T cells in patients with sight-threatening uveitis.
      Lee RW, Schewitz LP, Nicholson LB, Dayan CM, Dick AD, Invest Ophthalmol Vis Sci, Volume 50, 9 (September 2009) pp.4273-4278
    • The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey.
      Estcourt S, Hickey J, Perros P, Dayan C, Vaidya B, Eur J Endocrinol, Volume 161, 3 (September 2009) pp.483-487
    • CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope (vol 118, pg 3390, 2008)
      Skowera A, Ellis RJ, Varela-Calvino R, Arif S, Huang GC, Van-Krinks C, Zaremba A, Rackham C, Allen JS, Tree TIM, Zhao M, Dayan CM, Sewell AK, Unger WW, Drijfhout JW, Ossendorp F, Roep BO, Peakman M, Journal Of Clinical Investigation, Volume 119, 9 (September 2009) pp.2843-2843
    • The effects of cytokines on suppression of lymphocyte proliferation by dexamethasone.
      Creed TJ, Lee RW, Newcomb PV, di Mambro AJ, Raju M, Dayan CM, J Immunol, Volume 183, 1 (July 2009) pp.164-171
    • Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients.
      Panicker V, Saravanan P, Vaidya B, Evans J, Hattersley AT, Frayling TM, Dayan CM, J Clin Endocrinol Metab, Volume 94, 5 (May 2009) pp.1623-1629
    • Novel insights into thyroid hormones from the study of common genetic variation.
      Dayan CM, Panicker V, Nat Rev Endocrinol, Volume 5, 4 (April 2009) pp.211-218
    • Thyroid function and the natural history of depression: findings from the Caerphilly Prospective Study (CaPS) and a meta-analysis.
      Williams MD, Harris R, Dayan CM, Evans J, Gallacher J, Ben-Shlomo Y, Clin Endocrinol (Oxf), Volume 70, 3 (March 2009) pp.484-492
    • Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study.
      Thrower SL, James L, Hall W, Green KM, Arif S, Allen JS, Van-Krinks C, Lozanoska-Ochser B, Marquesini L, Brown S, Wong FS, Dayan CM, Peakman M, Clin Exp Immunol, Volume 155, 2 (February 2009) pp.156-165
    • Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture.
      Allen JS, Pang K, Skowera A, Ellis R, Rackham C, Lozanoska-Ochser B, Tree T, Leslie RD, Tremble JM, Dayan CM, Peakman M, Diabetes, Volume 58, 1 (January 2009) pp.138-145
    • Glucocorticoids and the emerging importance of T cell subsets in steroid refractory diseases.
      Schewitz LP, Lee RW, Dayan CM, Dick AD, Immunopharmacol Immunotoxicol, Volume 31, 1 (2009) pp.1-22
  • 2008
    • Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes.
      Lawson JM, Tremble J, Dayan C, Beyan H, Leslie RD, Peakman M, Tree TI, Clin Exp Immunol, Volume 154, 3 (December 2008) pp.353-359
    • CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope
      Skowera A, Ellis RJ, Varela-Calvino R, Arif S, Huang GC, Van-Krinks C, Zaremba A, Rackham C, Allen JS, Tree TIM, Zhao M, Dayan CM, Sewell AK, Unger W, Drijfhout JW, Ossendorp F, Roep BO, Peakman M, Journal Of Clinical Investigation, Volume 118, 10 (October 2008) pp.3390-3402
    • Reducing the burden of chronic wounds: prevention and management of the diabetic foot in the context of clinical guidelines.
      Searle A, Gale L, Campbell R, Wetherell M, Dawe K, Drake N, Dayan C, Tarlton J, Miles J, Vedhara K, J Health Serv Res Policy, Volume 13 Suppl 3 (October 2008) pp.82-91
    • Regulatory T cells in autoimmune endocrine diseases
      Wong FS, Dayan CM, Trends In Endocrinology And Metabolism, Volume 19, 8 (October 2008) pp.292-299
    • Regulatory T cells in autoimmune endocrine diseases.
      Wong FS, Dayan CM, Trends Endocrinol Metab, Volume 19, 8 (October 2008) pp.292-299
    • A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine.
      Panicker V, Cluett C, Shields B, Murray A, Parnell KS, Perry JR, Weedon MN, Singleton A, Hernandez D, Evans J, Durant C, Ferrucci L, Melzer D, Saravanan P, Visser TJ, Ceresini G, Hattersley AT, Vaidya B, Dayan CM, Frayling TM, J Clin Endocrinol Metab, Volume 93, 8 (August 2008) pp.3075-3081
    • Human CD8 responses to a complete epitope set from preproinsulin: implications for approaches to epitope discovery.
      Baker C, Petrich de Marquesini LG, Bishop AJ, Hedges AJ, Dayan CM, Wong FS, J Clin Immunol, Volume 28, 4 (July 2008) pp.350-360
    • A genome-wide association study identifies protein quantitative trait loci (pQTLs).
      Melzer D, Perry JR, Hernandez D, Corsi AM, Stevens K, Rafferty I, Lauretani F, Murray A, Gibbs JR, Paolisso G, Rafiq S, Simon-Sanchez J, Lango H, Scholz S, Weedon MN, Arepalli S, Rice N, Washecka N, Hurst A, Britton A, Henley W, van de Leemput J, Li R, Newman AB, Tranah G, Harris T, Panicker V, Dayan C, Bennett A, McCarthy MI, Ruokonen A, Jarvelin MR, Guralnik J, Bandinelli S, Frayling TM, Singleton A, Ferrucci L, Plos Genet, Volume 4, 5 (May 2008) p. e1000072
    • Preparing for first-in-man studies: the challenges for translational immunology post-TGN1412.
      Dayan CM, Wraith DC, Clin Exp Immunol, Volume 151, 2 (February 2008) pp.231-234
    • Do patients' beliefs about type 2 diabetes differ in accordance with complications: an investigation into diabetic foot ulceration and retinopathy.
      Searle A, Wetherell MA, Campbell R, Dayan C, Weinman J, Vedhara K, Int J Behav Med, Volume 15, 3 (2008) pp.173-179
    • Do patients' beliefs about type 2 diabetes differ in accordance with complications: An investigation into diabetic foot ulceration and retinopathy
      Searle A, Wetherell MA, Campbell R, Dayan C, Weinman J, Vedhara K, International Journal Of Behavioral Medicine, Volume 15, 3 (2008) pp.173-179
    • Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: a multi-centre, double-masked, factorial randomised controlled trial.
      Rajendram R, Lee RW, Potts MJ, Rose GE, Jain R, Olver JM, Bremner F, Hurel S, Cook A, Gattamaneni R, Tomlinson M, Plowman N, Bunce C, Hollinghurst SP, Kingston L, Jackson S, Dick AD, Rumsey N, Morris OC, Dayan CM, Uddin JM, Trials, Volume 9 (2008) p. 6
  • 2007
    • CD4+CD25(int) T cells in inflammatory diseases refractory to treatment with glucocorticoids.
      Lee RW, Creed TJ, Schewitz LP, Newcomb PV, Nicholson LB, Dick AD, Dayan CM, J Immunol, Volume 179, 11 (December 2007) pp.7941-7948
    • Kikuchi-Fujimoto disease manifesting as recurrent thrombocytopenia and Mobitz type II atrioventricular block in a 7-year-old girl: a case report and analysis of 138 Chinese childhood Kikuchi-Fujimoto cases with 10 years of follow-up in 97 patients.
      Jun-Fen F, Chun-Lin W, Li L, Dayan C, Guan-Ping D, Fang H, Acta Paediatr, Volume 96, 12 (December 2007) pp.1844-1847
    • Cytotoxic preproinsulin-specific CD8 T cells in type 1 diabetes in man
      Skowera A, Ellis R, Varela-Calvino R, Arif S, Van-Krinks C, Zhao M, Huang GC, Dayan C, Driffhout JW, Roep B, Peakman M, Acta Diabetologica, Volume 44 (November 2007) pp.S48-S49
    • Regulatory and proinflammatory islet-specific T cells in low risk first-degree relatives of subjects with type 1 diabetes
      De Marquesini LP, Fu J, Connor K, Wiggani S, Bishop A, McLintock N, Baker C, Arif S, Von Krinks C, Peaknian M, Wong S, Dayan CM, Acta Diabetologica, Volume 44 (November 2007) pp.S10-S11
    • Detection of islet-autoantigen-specific, IL-17-secreting CD4 T cells in type I diabetes in man
      Arif S, Shariff H, Dayan C, Peakman M, Acta Diabetologica, Volume 44 (November 2007) pp.S2-S3
    • Detection of autoreactive CD8 T-CELLS using MHC class I tetramers loaded with islet autoantigenic peptides in patients with type I diabetes
      Arif S, Skowera A, Shariff H, Dayan C, Bingley PJ, Roep BO, Drijjhout JW, Peakman M, Acta Diabetologica, Volume 44 (November 2007) pp.S39-S39
    • Proinsulin peptide administration: A phase 1 study initial report
      Wiggam S, James L, Arif S, Peakman M, Dayan C, Acta Diabetologica, Volume 44 (November 2007) pp.S55-S55
    • Dysthyroid optic neuropathy: a clinical diagnosis or a definable entity?
      Dayan CM, Dayan MR, Br J Ophthalmol, Volume 91, 4 (April 2007) pp.409-410
    • Twenty-four hour hormone profiles of TSH, Free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy.
      Saravanan P, Siddique H, Simmons DJ, Greenwood R, Dayan CM, Exp Clin Endocrinol Diabetes, Volume 115, 4 (April 2007) pp.261-267
    • Regulatory T cell responses detected by cytokine ELISPOT in type 1 diabetes
      Connor K, Marquesini L, Fu J, Bishop A, Wiggam S, Arif S, Krinks C, Peakman M, Dayan C, Diabetic Medicine, Volume 24 (March 2007) pp.37-37
    • Activated T cell subsets in human type 1 diabetes: evidence for expansion of the DR+ CD30+ subpopulation in new-onset disease.
      Baker C, Chang L, Elsegood KA, Bishop AJ, Gannon DH, Narendran P, Leech NJ, Dayan CM, Clin Exp Immunol, Volume 147, 3 (March 2007) pp.472-482
    • Proinsulin peptide as a diabetes vaccine: initial report from a phase one study
      Wiggam SL, Arif S, Hall W, Peakman M, Dayan CM, Diabetic Medicine, Volume 24 (March 2007) pp.44-45
    • Magnetic resonance imaging: a reliable method for measuring pancreatic volume in Type 1 diabetes.
      Williams AJ, Chau W, Callaway MP, Dayan CM, Diabet Med, Volume 24, 1 (January 2007) pp.35-40
  • 2006
    • Early activation of the inhibin B/FSH axis in obese Tanner stage G1PH1 boys.
      Fu JF, Dong GP, Liang L, Jiang YJ, Chen LQ, Dayan C, Clin Endocrinol (Oxf), Volume 65, 3 (September 2006) pp.327-332
    • Psychological well-being correlates with free thyroxine but not free 3,5,3'-triiodothyronine levels in patients on thyroid hormone replacement.
      Saravanan P, Visser TJ, Dayan CM, J Clin Endocrinol Metab, Volume 91, 9 (September 2006) pp.3389-3393
    • Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease.
      Creed TJ, Probert CS, Norman MN, Moorghen M, Shepherd NA, Hearing SD, Dayan CM, BASBUC INVESTIGATORS None, Aliment Pharmacol Ther, Volume 23, 10 (May 2006) pp.1435-1442
  • 2005
    • Partial substitution of thyroxine (T4) with tri-iodothyronine in patients on T4 replacement therapy: results of a large community-based randomized controlled trial.
      Saravanan P, Simmons DJ, Greenwood R, Peters TJ, Dayan CM, J Clin Endocrinol Metab, Volume 90, 2 (February 2005) pp.805-812
    • Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.
      Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, Tree TI, Diabetes, Volume 54, 1 (January 2005) pp.92-99
  • 2004
    • Dendritic cell-based assays, but not mannosylation of antigen, improves detection of T-cell responses to proinsulin in type 1 diabetes.
      Narendran P, Elsegood K, Leech NJ, Macindoe WM, Boons GJ, Dayan CM, Immunology, Volume 111, 4 (April 2004) pp.422-429
    • Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health
      Arif S, Tree TI, Astill TP, Tremble JM, Bishop AJ, Dayan CM, Roep BO, Peakman M, Journal Of Clinical Investigation, Volume 113, 3 (February 2004) pp.451-463
    • Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health.
      Arif S, Tree TI, Astill TP, Tremble JM, Bishop AJ, Dayan CM, Roep BO, Peakman M, J Clin Invest, Volume 113, 3 (February 2004) pp.451-463
  • 2003
    • Corticotropin-releasing hormone immunoreactivity in human T and B cells and macrophages: colocalization with arginine vasopressin.
      Baker C, Richards LJ, Dayan CM, Jessop DS, J Neuroendocrinol, Volume 15, 11 (November 2003) pp.1070-1074
    • Insulin injection abscesses caused by Mycobacterium chelonae.
      Finucane K, Ambrey P, Narayan S, Archer CB, Dayan C, Diabetes Care, Volume 26, 8 (August 2003) pp.2483-2484
    • Human monoclonal thyroid-stimulating autoantibody: how useful is a holy grail?
      Dayan CM, Lancet, Volume 362, 9378 (July 2003) pp.92-93
    • Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.
      Creed TJ, Norman MR, Probert CS, Harvey RF, Shaw IS, Smithson J, Anderson J, Moorghen M, Gupta J, Shepherd NA, Dayan CM, Hearing SD, Aliment Pharmacol Ther, Volume 18, 1 (July 2003) pp.65-75
    • Misconceptions in thyroid eye disease.
      Dayan CM, Practitioner, Volume 247, 1648 (July 2003) pp.570-580
    • Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes.
      Narendran P, Williams AJ, Elsegood K, Leech NJ, Dayan CM, Diabetes Metab Res Rev, Volume 19, 1 (January 2003) pp.52-59
  • 2002
    • Thyroid-stimulating-hormone concentrations and risk of hypothyroidism - Reply
      Dayan CM, Saravanan P, Bayly G, Lancet, Volume 360, 9350 (December 2002) pp.2082-2082
    • Pharmacotherapeutics and the endocrine system: blocking, replacing and exploiting nature's magic bullets.
      Dayan CM, Lightman SL, Curr Opin Pharmacol, Volume 2, 6 (December 2002) pp.691-693
    • Pharmacotherapeutics and the endocrine system: blocking, replacing and exploiting nature's magic bullets - Editorial overview
      Dayan CM, Lightman SL, Current Opinion In Pharmacology, Volume 2, 6 (December 2002) pp.691-693
    • Psychological well-being in patients on 'adequate' doses of l-thyroxine: results of a large, controlled community-based questionnaire study.
      Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM, Clin Endocrinol (Oxf), Volume 57, 5 (November 2002) pp.577-585
    • Whose normal thyroid function is better--yours or mine?
      Dayan CM, Saravanan P, Bayly G, Lancet, Volume 360, 9330 (August 2002) p. 353
    • Whose normal thyroid function is better - yours or mine?
      Dayan CM, Saravanan P, Bayly G, Lancet, Volume 360, 9330 (August 2002) pp.353-354
    • Characterization of the T-cell response to coxsackievirus B4: evidence that effector memory cells predominate in patients with type 1 diabetes.
      Varela-Calvino R, Ellis R, Sgarbi G, Dayan CM, Peakman M, Diabetes, Volume 51, 6 (June 2002) pp.1745-1753
    • Reproducibility of individualized coronary heart disease risk calculations in patients with diabetes mellitus.
      Lambert AP, Hunt MA, Day AP, Bayly GR, Dayan CM, Diabet Med, Volume 19, 6 (June 2002) pp.514-517
    • Steroid enhancing effect of the interleukin-2 antagonist basiliximab on lymphocyte steroid sensitivity
      Hearing SD, Crowley C, Creed T, Norman M, Dayan C, Gastroenterology, Volume 122, 4 (April 2002) pp.A400-A400
    • Steroid enhancing effect of the interleukin-2 antagonist basiliximab on lymphocyte steroid sensitivity
      Hearing SD, Crowley CJ, Creed TJ, Norman MN, Dayan CM, Gut, Volume 50 (April 2002) pp.A27-A27
  • 2001
    • Antigen-specific immunotherapy for autoimmune disease: fighting fire with fire?
      Peakman M, Dayan CM, Immunology, Volume 104, 4 (December 2001) pp.361-366
    • T cell activation by coxsackievirus B4 antigens in type 1 diabetes mellitus: evidence for selective TCR Vbeta usage without superantigenic activity.
      Varela-Calvino R, Sgarbi G, Wedderburn LR, Dayan CM, Tremble J, Peakman M, J Immunol, Volume 167, 6 (September 2001) pp.3513-3520
    • Stressful life events and Graves' disease revisited.
      Dayan CM, Clin Endocrinol (Oxf), Volume 55, 1 (July 2001) pp.13-14
    • Thyroid autoantibodies.
      Saravanan P, Dayan CM, Endocrinol Metab Clin North Am, Volume 30, 2 (June 2001) pp.315-viii
    • Thyroid autoantibodies
      Saravanan P, Dayan CM, Endocrinology And Metabolism Clinics Of North America, Volume 30, 2 (June 2001) pp.315-+
    • Interpretation of thyroid function tests.
      Dayan CM, Lancet, Volume 357, 9256 (February 2001) pp.619-624
  • 2000
    • The first Internet reproductive medicine clinical training programme with fully integrated workshops in the UK
      Jenkins JM, Cooling H, Watt M, Dayan C, DeBerker D, Tobias J, Cahill DC, Human Reproduction, Volume 15 (June 2000) pp.175-175
    • Role of biochemical assessment in management of corticosteroid withdrawal.
      Walsh JP, Dayan CM, Ann Clin Biochem, Volume 37 ( Pt 3) (May 2000) pp.279-288
    • Lymphocyte steroid sensitivity (LSS) in remission and outcome of steroid therapy for severe ulcerative colitis (UC)
      Hearing SD, Probert CSJ, Norman M, Dayan CM, Gut, Volume 46 (April 2000) pp.A7-A7
    • Lymphocyte steroid sensitivity (LSS) in remission and outcome of steroid therapy for severe ulcerative colitis (UC).
      Hearing SD, Probert CSJ, Norman M, Dayan CM, Gastroenterology, Volume 118, 4 (April 2000) pp.A791-A791
    • Effective formation of major histocompatibility complex class II-peptide complexes from endogenous antigen by thyroid epithelial cells.
      Maile R, Elsegood KA, Harding TC, Uney JB, Stewart CE, Banting G, Dayan CM, Immunology, Volume 99, 3 (March 2000) pp.367-374
  • 1999
    • Wide variation in lymphocyte steroid sensitivity among healthy human volunteers.
      Hearing SD, Norman M, Smyth C, Foy C, Dayan CM, J Clin Endocrinol Metab, Volume 84, 11 (November 1999) pp.4149-4154
    • Radioiodine and thyroid eye disease - Reply
      Walsh JP, Dayan CM, British Medical Journal, Volume 319, 7217 (October 1999) pp.1134-1134
    • Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes.
      Hearing SD, Norman M, Probert CS, Haslam N, Dayan CM, Gut, Volume 45, 3 (September 1999) pp.382-388
    • T helper 1 profile of recently activated circulating T cells in type 1 diabetes.
      Leech NJ, Elsegood KA, Narendran P, Hubbard A, Dayan CM, Diabetologia, Volume 42 (August 1999) pp.A100-A100
    • Radioiodine and thyroid eye disease - Use with caution
      Walsh JP, Dayan CM, Potts MJ, British Medical Journal, Volume 319, 7202 (July 1999) pp.68-69
    • Radioiodine and thyroid eye disease.
      Walsh JP, Dayan CM, Potts MJ, Bmj, Volume 319, 7202 (July 1999) pp.68-69
    • In vitro measurement of lymphocyte steroid sensitivity: lack of agreement between whole blood culture and separated lymphocyte culture.
      Hearing SD, Norman M, Dayan CM, Immunopharmacol Immunotoxicol, Volume 21, 1 (February 1999) pp.41-53
  • 1998
    • Controversies in the management of Graves' disease.
      Leech NJ, Dayan CM, Clin Endocrinol (Oxf), Volume 49, 3 (September 1998) pp.273-280
  • 1997
    • Effects of Acute Stress or Centrally Injected Interleukin-1beta on Neuropeptide Expression in the Immune System.
      Jessop DS, Douthwaite JA, Conde GL, Lightman SL, Dayan CM, Harbuz MS, Stress, Volume 2, 2 (December 1997) pp.133-144
    • Predicting outcome in severe ulcerative colitis by measuring steroid sensitivity of proliferating lymphocytes
      Hearing SD, Haslam N, Probert CSJ, Heaton KW, Norman M, Dayan C, Lightman SL, Gut, Volume 41 (October 1997) pp.A228-A228
    • FasL expression on epithelial cells: the Bottazzo-Feldman hypothesis revisited.
      Dayan CM, Elsegood KA, Maile R, Immunol Today, Volume 18, 5 (May 1997) p. 203
    • Functionality of inducible major histocompatibility class II expression by specialised non-lymphoid cells
      Maile R, Elsegood KA, Dayan CM, Biochemical Society Transactions, Volume 25, 2 (May 1997) pp.S318-S318
    • An antisense oligodeoxynucleotide complementary to corticotropin-releasing hormone mRNA inhibits rat splenocyte proliferation in vitro.
      Jessop DS, Harbuz MS, Snelson CL, Dayan CM, Lightman SL, J Neuroimmunol, Volume 75, 1-2 (May 1997) pp.135-140
    • Functionality of inducible major histocompatibility class II expression by specialised non-lymphoid cells.
      Maile R, Elsegood KA, Dayan CM, Biochem Soc Trans, Volume 25, 2 (May 1997) p. 318S
  • 1996
    • Functionality of inducible major histocompatibility class II expression by specialised non-lymphoid cells
      Maile R, Elsegood KA, Dayan CM, Immunology, Volume 89 (November 1996) pp.BB318-BB318
    • Chronic autoimmune thyroiditis (vol 335, pg 99, 1996)
      Dayan CM, New England Journal Of Medicine, Volume 335, 14 (October 1996) pp.1079-1079
    • Chronic autoimmune thyroiditis.
      Dayan CM, Daniels GH, N Engl J Med, Volume 335, 2 (July 1996) pp.99-107
    • Biochemical cure of recurrent acromegaly by resection of cervical spinal canal metastases.
      Dayan C, Guilding T, Hearing S, Thomas P, Nelson R, Moss T, Bradshaw J, Levy A, Lightman S, Clin Endocrinol (Oxf), Volume 44, 5 (May 1996) pp.597-602
    • Human self-reactive T cell clones expressing identical T cell receptor beta chains differ in their ability to recognize a cryptic self-epitope.
      Quaratino S, Feldmann M, Dayan CM, Acuto O, Londei M, J Exp Med, Volume 183, 2 (February 1996) pp.349-358
  • 1995
    • The 1995 Advanced Medicine Conference.
      Dayan C, Jackson M, J R Coll Physicians Lond, Volume 29, 4 (July 1995) pp.344-348
    • Identification of thyroid stimulating hormone receptor-specific T cells in Graves' disease thyroid using autoantigen-transfected Epstein-Barr virus-transformed B cell lines.
      Mullins RJ, Cohen SB, Webb LM, Chernajovsky Y, Dayan CM, Londei M, Feldmann M, J Clin Invest, Volume 96, 1 (July 1995) pp.30-37
    • Acute respiratory distress secondary to Morgagni diaphragmatic herniation in an adult.
      Wong NA, Dayan CM, Virjee J, Heaton KW, Postgrad Med J, Volume 71, 831 (January 1995) pp.39-41
    • ADVANCED MEDICINE CONFERENCE
      DAYAN C, JACKSON M, Journal Of The Royal College Of Physicians Of London, Volume 29, 4 (1995) pp.344-348
  • 1994
    • Transfection of thyroid autoantigens into EBV-transformed B cell lines. Recognition by Graves' disease thyroid T cells.
      Mullins RJ, Chernajovsky Y, Dayan C, Londei M, Feldmann M, J Immunol, Volume 152, 11 (June 1994) pp.5572-5580
  • 1993
    • T cells involved in human autoimmune disease are resistant to tolerance induction.
      Dayan CM, Chu NR, Londei M, Rapoport B, Feldmann M, J Immunol, Volume 151, 3 (August 1993) pp.1606-1613
    • PROVIDER POWER - AN IMPORTANT LESSON FROM THE UNITED-STATES HEALTH-CARE MARKET
      DAYAN C, Journal Of The Royal College Of Physicians Of London, Volume 27, 3 (July 1993) pp.238-241
    • Provider power: an important lesson from the US health care market.
      Dayan CM, J R Coll Physicians Lond, Volume 27, 3 (July 1993) pp.238-241
    • Determinant spreading and the dynamics of the autoimmune T-cell repertoire.
      Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammon G, Immunol Today, Volume 14, 5 (May 1993) pp.203-208
    • DEFINITION OF THE TRI-MOLECULAR COMPLEX OF HUMAN THYROID PEROXIDASE SPECIFIC AUTOREACTIVE T-CELL CLONES
      QUARATINO S, DAYAN C, FELDMANN M, LONDEI M, Journal Of Cellular Biochemistry (February 1993) pp.72-72
  • 1992
    • Autoimmune thyroiditis and targeted anti-T cell immunotherapy in man.
      Dayan CM, Feldmann M, Rapoport B, Londei M, Autoimmunity, Volume 11, 3 (1992) pp.189-198
    • Mechanism of Graves thyroiditis: implications for concepts and therapy of autoimmunity.
      Feldmann M, Dayan C, Grubeck-Loebenstein B, Rapoport B, Londei M, Int Rev Immunol, Volume 9, 2 (1992) pp.91-106
  • 1991
    • Autoantigen recognition by thyroid-infiltrating T cells in Graves disease.
      Dayan CM, Londei M, Corcoran AE, Grubeck-Loebenstein B, James RF, Rapoport B, Feldmann M, Proc Natl Acad Sci U S A, Volume 88, 16 (August 1991) pp.7415-7419
  • 1990
    • Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-3 on human thyroid epithelial cells in Graves' and Hashimoto's diseases.
      Zheng RQ, Abney ER, Grubeck-Loebenstein B, Dayan C, Maini RN, Feldmann M, J Autoimmun, Volume 3, 6 (December 1990) pp.727-736
• Conference proceedings
  • 2011
    • Epitope selection and protocol optimisation for peptide immunotherapy of type I diabetes in man using a humanised mouse model
      Janicki CN, Ali MA, Dayan CM, Wong FS, Immunology, Volume 135 (December 2011) pp.178-178
    • Pancreatic atrophy is apparent at the onset of type 1 diabetes in adults
      Williams AJK, Thrower SJ, Sequeiros IM, Ward A, Bickerton AS, Triay JM, Callaway MP, Dayan CM, Diabetologia, Volume 54 (September 2011) pp.S157-S157
    • Optimising the tolerogenic potential of a 'vaccine' for type 1 diabetes by topical betamethasone therapy
      Ali MA, Thrower S, Harris S, Wong S, Dayan CM, Diabetologia, Volume 54 (September 2011) pp.S88-S89
    • PREVALENCE OF ABNORMAL LIVER FUNCTION AND RESPONSE TO LIFESTYLE INTERVENTIONS IN NEWLY DIAGNOSED TYPE 2 DIABETES: PRELIMINARY RESULTS OF A UK RANDOMISED CONTROLLED STUDY
      Parker R, Guthrie N, Patel N, Woltersdorf W, Andrews R, Dayan C, McCune CA, ACTID E, Gut, Volume 60 (April 2011) pp.A59-A59
    • PREVALENCE OF ABNORMAL LIVER FUNCTION AND RESPONSE TO LIFESTYLE INTERVENTIONS IN NEWLY DIAGNOSED TYPE 2 DIABETES: PRELIMINARY RESULTS OF A UK RANDOMISED CONTROLLED STUDY
      Parker R, Guthrie N, Patel N, Woltersdorf W, Andrews R, Dayan CM, ACTID E, Journal Of Hepatology, Volume 54 (March 2011) pp.S343-S343
  • 2010
    • A study of antigen presenting cells taking up peptide following intradermal peptide administration for peptide immunotherapy
      Harris SJ, Ali MA, Wong FS, Dayan CM, Immunology, Volume 131 (December 2010) pp.132-133
    • Direct ex vivo Enumeration of CD8 T Cells Specific for beta-cell Autoantigens by Peptide-HLA Multimers in Type 1 Diabetes
      Skowera A, Arif S, Zaremba A, Dayan C, Roep B, Sewell A, Peakman M, Clinical Immunology, Volume 135 (2010) pp.S21-S21
  • 2009
    • IN-VITRO STEROID RESISTANCE IN SEVERE ALCOHOLIC HEPATITIS PREDICTS TREATMENT RESPONSE AND OUTCOME
      di Mambro AJ, Parker R, McCune A, Gordon FH, Dayan CM, Collins P, Hepatology, Volume 50, 4 (October 2009) pp.606A-606A
    • Sensor augmented pump therapy substantially lowers HbA(1c); a randomized controlled trial
      Hermanides J, Norgaard K, Bruttomesso D, Mathieu C, Frid A, Dayan CM, Diem P, Fermon C, Wentholt IME, Hoekstra JBL, DeVries JH, Diabetologia, Volume 52 (September 2009) pp.S43-S43
    • A Randomized, Double-Blind, Placebo-Controlled Trial of Basiliximab with Concomitant Corticosteroids in Steroid-Refractory Ulcerative Colitis
      Sands BE, Sandborn WE, Creed TJ, Dayan CM, Van Assche GA, Stempien MJ, Levitt D, Probert CS, Gastroenterology, Volume 136, 5 (May 2009) pp.A65-A65
  • 2008
    • Identification of steroid refractory CD4(+) T cells in patients with intraocular inflammation (uveitis)
      Lee RWJ, Schewitz LP, Nicholson LB, Dayan CM, Dick AD, Immunology, Volume 125 (December 2008) pp.104-104
    • Immunotherapy for type 1 diabetes: identification of potentially therapeutic peptides using a humanised mouse model
      Pope C, Brown S, Siew LK, Peakman M, Wen L, Dayan CM, Wong FS, Immunology, Volume 125 (December 2008) pp.136-137
  • 2007
    • Weight loss resulting from bariatric surgery in morbidly obese insulin resistant individuals leads to improvements in insulin signaling
      Chen MZ, Hudson CA, Vincent EE, Dayan CM, DeBerker D, Tavare JM, Andrews RC, Diabetologia, Volume 50 (September 2007) pp.S252-S253
    • Detection of regulatory and proinflammatory islet-peptide specific T cells in Type 1 diabetes
      Marquesini L, Fu J, Connor K, Wong FS, Arif S, Peakman M, Van Krinks C, Dayan CM, Immunology, Volume 120 (March 2007) pp.38-38
    • Responses of CD8 T cells to preproinsulin are heterogeneous in patients with type 1 diabetes
      Baker C, de Marquesini LGP, Bishop AJ, Dayan CM, Wong FS, Immunology, Volume 120 (March 2007) pp.70-71
    • Proinsulin peptide as a diabetes vaccine: a phase 1 study initial report
      Wiggam SL, Arif S, Hall W, Peakman M, Dayan CM, Immunology, Volume 120 (March 2007) pp.71-71
  • 2005
    • Development of a flow cytometric assay to predict an individual's CD4 lymphocyte response to immunosuppression
      Lee R, Dayan C, Norman M, Dick A, Investigative Ophthalmology & Visual Science, Volume 46 (2005)
  • 2004
    • Anti-CD25 therapy and the role of cytokines in lymphocyte steroid resistance
      Creed T, Hearing S, Crowley C, Norman M, Dayan C, Gastroenterology, Volume 126, 4 (April 2004) pp.A567-A567
    • Basiliximab (anti-CD25) for the treatment of steroid resistant ulcerative colitis
      Creed T, Probert C, Dayan C, Hearing S, Gastroenterology, Volume 126, 4 (April 2004) pp.A75-A75
    • Basiliximab for the treatment of steroid resistant ulcerative colitis
      Creed TJ, Dayan CM, Probert CSJ, Hearing SD, Gut, Volume 53 (April 2004) pp.A97-A97
  • 2003
    • Basiliximab (IL-2 receptor antagonist) as a steroid sensitising agent in steroid resistant ulcerative colitis
      Creed T, Hearing S, Probert C, Norman M, Dayan C, Gastroenterology, Volume 124, 4 (April 2003) pp.A7-A7
  • 2002
    • Dendritic cell-based proliferative assays of peripheral T cell responses to tetanus toxoid.
      Narendran P, Elsegood K, Leech NJ, Dayan CM, , United States Ann N Y Acad Sci, Volume 958 (April 2002) pp.170-174
  • 1995
    • Human autoreactive T-cell clones show flexibility in recognizing overlapping microepitopes, but inflexibility in T-cell receptor usage.
      Londei M, Dayan C, Feldmann M, Acuto O, Quaratino S, , United States Ann N Y Acad Sci, Volume 756 (July 1995) pp.345-348
  • 1992
    • T cell activation and antigen presentation in human thyroid autoimmunity.
      Feldmann M, Dayan C, Rapoport B, Londei M, , England J Autoimmun, Volume 5 Suppl A (April 1992) pp.115-121
  • 1990
    • SPECIFIC RECOGNITION OF THYROID PEROXIDASE BY THYROID INFILTRATING T-CELL CLONES IN HUMAN AUTOIMMUNE-THYROIDITIS
      DAYAN C, LONDEI M, CORCORAN A, RAPOPORT B, FELDMANN M, Thyroperoxidase And Thyroid Autoimmunity, Volume 207 (1990) pp.267-267